MedTrace Logo

Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy

NCT03614052 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2020-01-31

No results posted yet for this study

Summary

This a study aiming to compare treatment with tamsulosin versus placebo in patients undergoing endoscopic treatment for urolithiasis. The main outcome is the rate of stone free patients.

Conditions

  • Ureterolithiasis
  • Ureteral Calculi
  • Urolithiasis

Interventions

DRUG

Tamsulosin Hydrochloride 0.4 milligrams

Tamsulosin hydrochloride 0,4mg for 5 days before ureteroscopic treatment of urolithiasis

DRUG

Placebo Oral Tablet

Placebo oral tablet 1 tablet per day for 5 days before ureteroscopic treatment of urolithiasis

Sponsors & Collaborators

  • Pontificia Universidad Catolica de Chile

    lead OTHER

Principal Investigators

  • Gaston Astroza, MD · Pontificia Universidad Catolica de Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2020-01-26
Completion
2020-01-26

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03614052 on ClinicalTrials.gov